Development and preclinical evaluation of an alphavirus replicon particle vaccine for cytomegalovirus

We used a replication-incompetent, single-cycle, alphavirus replicon vector system to produce virus-like replicon particles (VRP) expressing the extracellular domain of human cytomegalovirus (CMV) glycoprotein B or a pp65/IE1 fusion protein. Efficient production methods were scaled to produce pilot...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Reap, Elizabeth A., Morris, John, Dryga, Sergey A., Maughan, Maureen, Talarico, Todd, Esch, Robert E., Negri, Sarah, Burnett, Bruce, Graham, Andrew, Olmsted, Robert A., Chulay, Jeffrey D.
Formato: Artigo
Idioma:Inglês
Publicado: 2007
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC2744093/
https://ncbi.nlm.nih.gov/pubmed/17870214
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2007.08.016
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares